Sensor skin for Liver Cirrhosis
This trial found that measuring inflammation over time using a skin device was more predictive of disease outcomes than a single blood draw.
- Liver Cirrhosis
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are participants being sought after for this exploration?
"Yes, this investigation is actively recruiting. It was initially added to clinicaltrials.gov on September 1st of 2022 and updated most recently on the 9th of that same month. 60 patients need to be enrolled at a single facility for the trial's completion."
How many individuals are participating in this experiment?
"Affirmative. Clinicaltrials.gov's information demonstrates that this investigation is recruiting participants, which began being posted on September 1st 2022 and was recently revised on the 9th of September 2022. The research team needs to find 60 people from a single clinical site."